Stimwave Technologies recently announced that it named Aure Bruneau as CEO, effective immediately.
Bruneau succeeds Paul LaViolette, who was appointed interim CEO in late 2019.
“Are is a perfect match for the next fast-growth chapter at Stimwave,” LaViolette said in a news release. “He is a truly customer-centric leader and will continue our rapid expansion while creating a collaborative and success-oriented culture. Aure has been a magnet for talent, has driven both innovation and disciplined execution and is ideally suited to lead Stimwave.”
Prior to joining the company, Brunei led the robotic, CMF/thoracic and spine businesses of Zimmer Biomet. He has also held numerous leadership positions at Medtronic and Sofamor Danek.
“I am thrilled to have the opportunity to lead the Stimwave team, to help fulfill our mission to innovate in neuromodulation and provide unique solutions for patients with chronic pain. The Stimwave technology platform is one-of-a-kind and the company has had great success to date,” Bruneau said. “I am confident my passion for technology, business fundamentals, patients and the Stimwave team will help us achieve our clinical and business goals.”
